Living Diabetes is an evidence-based diabetes resource. Our editorial team curates clinical content from NICE, NHS, ADA and Diabetes UK guidelines to help readers understand and live well with diabetes.
A new FLOW analysis reports that semaglutide kidney and all-cause death benefits were consistent across cardiovascular-risk groups in adults with type 2 diabetes and chronic kidney disease.